| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.099 | 0.08 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |